August 11, 2018 How machines could mine forgotten data Drug discovery is getting harder, and some companies are turning to machine learning to look for new targets.
July 26, 2018 Glaxo needs acquisitions to become a big deal in oncology Glaxosmithkline is trying to reinvent itself as an oncology company – but it will need to make bolder deals if it wants to succeed.
